Burt, Richard K. http://orcid.org/0000-0002-0922-4145
Balabanov, Roumen
Tavee, Jinny
Han, Xiaoqiang
Sufit, Robert
Ajroud-Driss, Senda
Jovanovic, Borko
Quigley, Kathleen
Arnautovic, Indira
Helenowski, Irene
Sharrack, Basil
Article History
Received: 4 May 2020
Revised: 15 June 2020
Accepted: 18 June 2020
First Online: 27 June 2020
Compliance with ethical standards
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest except the following author. Rouman Balabanov—Scientific Advisory Boards-Biogen, Sanofi-Genzyme, Genentech, Alexion Speakers' Bureaus–Biogen Idec, Sanofi-Genzyme.
: Patients enrolled in this open-label prospective study were treated at Northwestern Memorial Hospital (Chicago, Illinois, USA) on an IRB and FDA approved protocol (ExternalRef removed NCT00278629) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All persons gave their informed consent prior to their inclusion in the study.